Ongoing Phase I Studies of Immune Checkpoint Inhibitors in China

BACKGROUND. Cancer immunotherapy targeting immune checkpoint inhibitors (ICIs) has been shown to be a promising strategy in the treatment of various malignancies. Despite the proven efficacy and tolerability of ICIs based on 113 clinical trials globally, data regarding the pharmacokinetic (PK) and p...

Full description

Saved in:
Bibliographic Details
Published in:Oncologist
Main Authors: Fang, Wenfeng, Zhao, Shen, Zhang, Yaxiong, Ma, Yuxiang, Zhao, Hongyun, Zhang, Li
Format: Artigo
Language:Inglês
Published: John Wiley & Sons, Inc. 2019
Subjects:
Immuno‐Oncology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6394776/
https://ncbi.nlm.nih.gov/pubmed/30819827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-IO-S1-s03
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items